Showing results (131-140 of 430) with videos related to

Sort By:
Pageof 43
Diabetes Care|February 7, 2009
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) programDavid Preiss, Sofia Zetterstrand, John J V McMurray, et al.
European Journal of Heart Failure|January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-PreservedJennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 13, 2017
Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT StudyRoberto S Kalil, Myra A Carpenter, Anastasia Ivanova, et al.
Circulation|December 7, 2005
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patientsScott D Solomon, Nagesh Anavekar, Hicham Skali, et al.
Circulation|September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli, Chris Isles, Gary C Curhan, et al.
European Journal of Heart Failure|January 30, 2009
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Nathaniel M Hawkins, Zhen Huang, Karen S Pieper, et al.
European Journal of Heart Failure|January 28, 2014
The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patientsGeorge V Moukarbel, Zi-Fan Yu, Kenneth Dickstein, et al.
American Heart Journal|November 19, 2011
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programCono A Ariti, John G F Cleland, Stuart J Pocock, et al.
European Journal of Heart Failure|June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trialKota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.
The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
Pageof 43